Tenders/Part 1. Vaccine against invasive Haemophilus influenzae type b infections, for mandatory vaccinations.
Awarded🇵🇱PolandSupplies

Part 1. Vaccine against invasive Haemophilus influenzae type b infections, for mandatory vaccinations.

Auto-translated from Polish
Original title: Część 1. Szczepionka przeciw inwazyjnym zakażeniom Haemophilus influenzae typu b, do szczepień obowiązkowych.
MINISTERSTWO ZDROWIA
Published: Jul 22, 2026
Updated: Jul 26, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Sanofi Sp. z o.o. — €15,400,000

Browse open Health & Medical tenders in Poland

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
1. The subject of the order is the delivery of a vaccine against invasive Haemophilus influenzae type b infections, for mandatory vaccinations, on the terms specified in the SWZ. 2. Total quantity (purchase volume): 40,000 doses. 3. When selecting the most advantageous offer, the Contracting Authority reserves the right to reduce the purchase of the medicinal product, but by no more than 20% of each part of the aforementioned subject of the order, in the event of exceeding the amount allocated for the execution of the order or the occurrence of objective and justified needs, in particular changes in patient demand. 4. Pursuant to art. 256 of the Pzp Act. The Contracting Authority may annul the public procurement procedure before the deadline for submitting offers, if circumstances arise that make further proceedings unjustified. 5. Pursuant to art. 257 of the Pzp Act. The Contracting Authority may annul the public procurement procedure if the public funds intended by the Contracting Authority to finance all or part of the order have not been granted to it. 6. By virtue of the Act of November 16, 2022, on amending the Act on the Medical Profession and Dentistry and certain other acts (Journal of Laws of 2022, item 2270), the Act of August 27, 2004, on health care benefits financed by public funds (Journal of Laws of 2024, item 146) has been included in financing by the National Health Fund for the purchase of vaccines used for mandatory vaccinations within the framework of the Vaccination Program and vaccines and other immunological medicinal products constituting reserves, used in case of an epidemic threat or epidemic. 7. Pursuant to art. 97 sec. 3 point 3d of the Act on health care benefits financed by public funds, the scope of the fund's activities also includes, in particular: financing the purchase of vaccines referred to in art. 18 sec. 5 of the Act of December 5, 2008, on the prevention and combating of infections and infectious diseases in humans, and medicinal products referred to in art. 18a sec. 2 of this Act. 8. The order must be executed in accordance with the requirements specified in the SWZ and the Draft Contract Provisions. 9. Subject-matter evidence: Pursuant to art. 105 and art. 106 Pzp. in order to confirm the compliance of the offered supplies with the requirements, characteristics or criteria specified in the description of the subject of the order or the criteria for evaluating offers or requirements related to the execution of the order, the Contracting Authority requests the Contractors to submit the following documents: • A valid marketing authorization for the medicinal product issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, or • A valid marketing authorization for the medicinal product issued by the Council of the European Union or the European Commission. 9.1. Pursuant to art. 107 sec. 1 of the Pzp Act. The Contractor is obliged to submit the aforementioned subject-matter evidence with the offer and should exercise all due diligence to ensure that these documents are complete and contain all necessary information enabling the Contracting Authority to verify their correctness. 9.2. The marketing authorization for the medicinal product must be valid and current on the day of submitting the offers. 9.3. The composition of the preparation and packaging must be consistent with the content of the documents referred to in point 9. 9.4. In the event that the validity of the document expires, the Contractor is obliged to provide the Contracting Authority with the documents referred to in point 9, along with an additional document declaring the timely submission of an application for extension of the validity of the marketing authorization for the medicinal product or, if obtained, a valid marketing authorization for the medicinal product. 9.5. The Contractor is obliged to inform the Contracting Authority about the transfer to another entity of the rights and obligations of the responsible entity resulting from the authorization ...

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on July 22, 2026. Last refreshed 115 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About MINISTERSTWO ZDROWIA

MINISTERSTWO ZDROWIA has issued 261 procurement notices on BidsFactory, including 4 currently open and 76 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Education & Training. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU), Poland e-Zamówienia, and Baza Konkurencyjności. Most recent publication: November 17, 2026.

MINISTERSTWO ZDROWIA: buyer profile, tenders and awards

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Sanofi Sp. z o.o. was awarded the contract for €15,400,000. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Sanofi Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by MINISTERSTWO ZDROWIA in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories